#healthcare #Abu Dhabi #UAE #PureHealth

Overview of PureHealth's Q1 2026 Performance

In a remarkable display of financial strength, PureHealth Holding PJSC, the leading healthcare group in the Middle East, has announced its financial results for the first quarter of 2026. The group reported a revenue of USD 2.0 billion, marking a 10% increase year-on-year, and a net profit of USD 113 million during this period. This performance demonstrates the resilience of the group's operations and its strategic importance in the healthcare sector.

Key Financial Figures

The reported EBITDA for PureHealth rose by 5% compared to the previous year, amounting to USD 323 million. The growth is attributed to the strong performance across its international portfolio and the Cover vertical, which includes insurance services. Overall, the company is positioned well to pursue ongoing growth opportunities, backed by a robust balance sheet with total assets totaling USD 15.6 billion.

Strong Growth Drivers

H.E. Kamal Al Maazmi, Chairman of PureHealth, indicated that the strong showing in Q1 reflects sustained demand and disciplined execution across their integrated Care and Cover model. The group's diverse geographical presence allows it to mitigate short-term impacts from regional changes while focusing on long-term growth strategies. Al Maazmi cited the importance of international expansion, particularly through acquisitions and partnerships, in bolstering revenue streams and solidifying PureHealth's market standing in the UAE and beyond.

Group CEO Shaista Asif echoed this sentiment, stating the company's commitment to enhancing clinical excellence and expanding globally. The report highlights a particularly impressive growth of 60% year-on-year for the international Care revenue, driven by contributions from the Hellenic Healthcare Group and Circle Health.

Operational Highlights

In terms of operational metrics, the financial breakdown reveals that the UAE's Care revenue decreased by 13% year-on-year to USD 745 million, largely due to regulatory shifts stemming from the Unified Purchasing Program (UPP) implemented in May 2025. However, activity levels in hospitals remained encouraging, with both outpatient and inpatient volumes increasing, reflecting the underlying strength of healthcare needs.

The Cover vertical, dealing with insurance, reported a 9% growth in revenue to USD 551 million. This figure was bolstered by a 5.6% year-on-year rise in gross written premiums. Moreover, the number of insured members climbed to 3.4 million, showcasing the effectiveness of customer engagement and retention strategies.

Strategic Initiatives and Future Outlook

Looking ahead, PureHealth appears well-equipped for sustained growth, with plans to continue expanding its international platform and improve service offerings. Recent strategic moves include Circle Health’s expansion of hospital services and their investment in advanced surgical technologies, such as the introduction of robotic surgery systems. The company also plans to enhance its logistics operations through AI-powered systems to improve operational efficiencies.

As the group invests further into its digital capabilities and property casualty lines, the outlook remains positive. There’s a clear focus on high-value, high-margin international portfolio growth as a key driver for the future, aiming to maintain its leadership position in healthcare.

Conclusion

PureHealth's robust Q1 2026 performance underscores the strength and resilience of its business model in an ever-evolving market. As the healthcare landscape shifts, the group's strategic initiatives in expansion and innovation should continue to position it for success. With ongoing investments in technology and service enhancement, PureHealth is set to reinforce its status as a leading healthcare provider, contributing significantly to the industry in the Middle East and beyond.